A symposium: Safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of Acute Coronary Syndromes
Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors
Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes
Bleeding complications of glycoprotein IIb-IIIa receptor inhibitors
Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy
Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon’s perspective
Understanding thrombocytopenia and antigenicity with glycoprotein IIb-IIIa inhibitors